Journal article
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations
Abstract
The treatment strategy for children and adolescents with chronic myeloid leukemia in the chronic phase (CML-CP) has evolved from allogeneic hematopoietic stem cell transplantation (HSCT) to tyrosine kinase inhibitors (TKIs). With the advent of next-generation TKIs and new targeted therapies in the CML field, an international pediatric CML expert panel provides recommendations based on the medical literature (including previous pediatric …
Authors
Millot F; Ampatzidou M; Moulik NR; Tewari S; Elhaddad A; Hammad M; Pichler H; Lion T; Tragiannidis A; Shima H
Journal
Leukemia, Vol. 39, No. 4, pp. 779–791
Publisher
Springer Nature
Publication Date
4 2025
DOI
10.1038/s41375-025-02543-4
ISSN
0887-6924